This study was conducted to analyse the presence of a plasmid-mediated carbapenem resistance mechanism in a clinical Enterobacter aerogenes isolate from a patient from Jiangsu province, People's Republic of China. PCR and sequencing confirmed that the isolate harboured Klebsiella pneumoniae carbapenemase (KPC)-2, DHA-1 and TEM-1 b-lactamase genes. Both the KPC-2 and DHA-1 genes were transferred to Escherichia coli C600 by transconjugation, and Southern blotting confirmed that these two genes were located on the same plasmid, which was of approximately 56 kb in size. The Enterobacter aerogenes isolate was resistant to carbapenems and other tested antimicrobial agents. The Escherichia coli transconjugant showed reduced susceptibility but not resistance to carbapenems and other b-lactams, indicating the presence of another, possibly permeability-related, resistance mechanism in the clinical isolate.
INTRODUCTION
Klebsiella pneumoniae carbapenemases (KPCs), the most frequent class A carbapenemases, were originally identified from K. pneumoniae isolated from North Carolina. Soon afterwards, these plasmid-mediated carbapenemases were identified in multiple genera and species of the Enterobacteriaceae and non-fermenters. The geographical distribution of bla KPC -producing isolates has spread not only within the USA (Bradford et al., 2004; Bratu et al., 2005) , but also in Israel (Navon-Venezia et al., 2006) , France (Naas et al., 2005) , Greece (Cuzon et al., 2008) , China (Shi et al., 2012) , Argentina and Brazil (Monteiro et al., 2009) .
Enterobacter species are important opportunistic pathogens that can cause nosocomial outbreaks and invasive infections such as bloodstream infections. The treatment of serious infections caused by Enterobacteriaceae producing AmpC cephalosporinases or extended-spectrum b-lactamases (ESBLs) depends mainly on carbapenems. The emergence of carbapenem-resistant strains may have serious consequences because of the limitation of therapeutic choices for patients with invasive Enterobacter aerogenes infections. In the present study, we describe an Enterobacter aerogenes isolate producing KPC-2 carbapenemase and DHA-1 AmpC enzyme, the isolate having been recovered from a patient undergoing hospital treatment.
METHODS
Bacterial strain. The carbapenem-resistant Enterobacter aerogenes WX04 strain was isolated from the sputum of a 69-year-old patient hospitalized in the intensive care unit on 3 July 2010. The patient suffered from primary biliary cirrhosis and had been admitted to the hospital on 4 May 2010. During hospitalization, imipenem was repeatedly administered (total dosage of imipenem received was 70 g). Species level identification of the isolate was confirmed by VITEK cards (bioMérieux) and standardized biochemical tests.
Antimicrobial susceptibility testing. Antibiotic sensitivity testing of Enterobacter aerogenes WX04 was performed by the agar dilution method (Mueller-Hinton agar; Oxoid). The results were interpreted according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI, 2009) . Interpretations of susceptibility for all antimicrobials tested were based on the CLSI criteria (CLSI, 2009) . Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were routinely included in the testing for quality assurance.
PCR amplification and DNA sequence analysis of bla genes.
DNA from the clinical isolate and Escherichia coli transconjugant was used as a template in PCR amplification. The primers used to amplify the carbapenemase genes bla KPC , bla IMP , bla VIM , bla SME , bla , bla IMI/NMC and bla GES-1 , the ESBL genes bla TEM , bla SHV and bla CTX-M , and the plasmid-borne AmpC genes, including those encoding MOX-1, MOX-2, CMY-1-CMY-11, LAT-1-LAT-4, BIL-1, DHA-1, DHA-2, AAC, MIR-1, ACT-1 and FOX-1-FOX-5b, were as described previously, as were the amplification conditions (Kuai et al., 2010; Smith Moland et al., 2003; Nüesch-Inderbinen et al., 1996; Rasheed et al., 1997; Edelstein et al., 2003 , Pérez-Pérez & Hanson, 2002 . PCR amplification products were purified and directly sequenced using an ABI 3730 Sequencer (Applied Biosystems) and the sequences were compared with the reported sequences from GenBank using the Basic Local Alignment Search Tool (BLAST) program. ) was used as the recipient strain. A conjugation experiment was carried out in mixed-broth cultures as described previously (Shi et al., 2012) . Escherichia coli transconjugants were selected on MuellerHinton agar plates containing 256 mg rifampicin ml 21 (Sigma) plus 1 mg imipenem ml
21
. Plasmid DNA from the Enterobacter aerogenes strain and its transconjugant was isolated by use of a plasmid DNA midi kit (Qiagen) according to the manufacturer's instructions. Plasmid DNA extracted from the original isolate and its transconjugant was electroporated on 0.8 % agarose gels in the presence of 1.0 Tris/ acetate-EDTA buffer (0.04 M Tris-Acetate, 0.001 M EDTA, pH 8.3). The DNA was then transferred to a Hybond-N+ membrane (Amersham Bioscience) and cross-linked by use of UV light. Primers of bla KPC-2 and bla DHA-1 labelled with a-32 P were used as specific probes. Meanwhile, the same plasmid DNA was used as a template to confirm the existence of bla KPC-2 and bla DHA-1 using specific primers.
Isoelectric focusing of b-lactamases. Crude cell lysates were prepared by ultrasonication from Enterobacter aerogenes WX04 and its transconjugant, as described previously (Navon-Venezia et al., 2006) . b-lactamases were characterized by analytical isoelectric focusing (IEF) with the PhastSystem (Pharmacia) according to established methods (Poirel et al., 2004) . Cell extracts were analysed by using commercially prepared polyacrylamide gel plates at pH 3.5-9.5 (Amersham-Pharmacia). b-lactamases were visualized by staining the IEF gel with a 0.05 % (0.96 mM) solution of nitrocefin (BD Biosciences). The isoelectric points of DHA-1 (7.8), KPC-2 (6.7) and TEM-1 (5.4) were estimated by comparison with those of TEM-1 (5.4), KPC-2 (6.7), SHV-18 (7.6) and ACT-1 (9.0) extracted from ATCC K. pneumoniae 700603, Enterobacter cloacae 029M and a clinical isolate of K. pneumoniae producing KPC-2 enzyme.
Analysis of the genetic environment of the bla KPC gene. The plasmid DNA extracted from the original isolate and the transconjugant was used as a template for PCR. Determination of the genetic environment around the KPC gene was accomplished by using primers CETnF1 (59-CAT GGC GTA GGT TGT TGT CGC-39) and CETnR1 (59-GCG GCA GAA GCC AAA ATC G-39) designed by Gootz et al. (2009) . The primer KPC-F1 (59-CGC CTA ACA AGG ATG ACA AG-39), which is identical to bp 799-818 of the KPC-2 gene (GenBank accession number AY034847) and the primer KPC-R1 (59-ACT TAC AGT TGC GCC CTG AGC-39), which is complementary to bp 179-160 of the KPC-2 gene (GenBank accession number AY034847) as well as sequences, were analysed by the use of the BLAST program.
RESULTS AND DISCUSSION
The results of the susceptibility testing are shown in Table  1 . The original isolate exhibited resistance to aztreonam as well as to carbapenem, cephalosporin and aminoglycoside antibiotics, but was not resistant to levofloxacin, suggesting a choice for clinical therapy. The MICs of expandedspectrum cephalosporins and carbapenems were only slightly modified after the addition of clavulanic acid.
Attempts to transfer reduced imipenem susceptibility from Enterobacter aerogenes WX04 to rifampicin-resistant Escherichia coli EC600 (LacZ 2 Nal r Rif r ) by a mixed-broth mating procedure (Wei et al., 2005) succeeded, indicating that the plasmid carrying the carbapenem resistance determinant possessed its own transfer-associated gene clusters. Mueller-Hinton agar containing 1 mg imipenem ml 21 and 256 mg rifampicin ml 21 was used to select the transconjugants. Transfer of the plasmid to a susceptible E. coli strain caused a significant increase in MICs but did not confer the same resistance level of imipenem and meropenem, suggesting that an additional mechanism is involved in carbapenem resistance in the Enterobacter aerogenes strain, such as alterations in outer membrane permeability. Plasmid DNA present in Enterobacter aerogenes WX04 and its transconjugant were extracted using the Qiagen plasmid midi kit; they all harboured a single plasmid with a size of approximately 56 kb (data not shown). The respective DNA extracts were subjected to specific PCR assays and sequencing for the bla KPC-2 and bla DHA-1 genes. It was confirmed that the two genes were located on the same 56 kb plasmid; the primers and PCR conditions used were as previously described (Kuai et al., 2010; Smith Moland et al., 2003) . Moreover, Southern hybridization revealed a positive signal for the 56 kb plasmid with either the bla KPC-2 or bla DHA-1 probes (data not shown), and the results of molecular hybridization assays were consistent with those obtained by PCR.
The results of isoelectric focusing showed that Enterobacter aerogenes WX04 had three b-lactamases with isoelectric point (pI) values of 5.4, 6.7 and 7.8, while its transconjugant had two b-lactamases with pI values of 6.7 and 7.8. PCR experiments using genomic DNA from the Enterobacter aerogenes isolate as a template, followed by sequencing, identified three b-lactamase genes coding for the carbapenemase KPC-2 (pI 6.7), the narrow-spectrum TEM-1(pI 5.4) and the DHA-1-type AmpC enzyme (pI 7.8).
Comparison with the plasmid analysis and transconjugant data showed that the TEM enzyme was not encoded on a plasmid (Fig. 1) .
Previous studies of the genetic environment of the bla KPC gene have identified a transposon-associated element, Tn4401, which was considered to be the reason for bla KPClike gene acquisition and dissemination (Naas et al., 2005) . However, in our present work, the genetic environment around bla KPC showed that no significant signal was acquired when the plasmid was sequenced with primers CETnF1 and CFTnR1, and revealed that the genetic environment around bla KPC in the original isolate and its transconjugant was not the transposon Tn4401 (Gootz et al., 2009) . The assembly results revealed a 2.6 kb sequence that was part of the genetic context of the bla KPC gene, from 5835 bp to 8434 bp in the plasmid pKP048 (GenBank accession no. FJ 28167.1) reported by Shen et al. (2009) . Outside this region, sequencing revealed a context for bla KPC , with the gene order Tn3-transposase, Tn3-resolvase, ISKpn8, the bla KPC-2 gene, and the ISKpn6-like element from Morganella morganii (Shi et al., 2012) (Fig. 2) . These results suggested that bla KPC-2 carried in the Enterobacter aerogenes isolate was possibly transferred between different species by the same mobile genetic element. This mode of transmission may increase the chance of bacteria acquiring carbapenem and cephalosporin resistance, causing serious nosocomial infection.
In conclusion, this report identified a carbapenem-resistant Enterobacter aerogenes producing DHA-1 AmpC enzyme and KPC-2 carbapenemase that probably resulted from an inter-species transfer of the KPC producer from Hangzhou, Zhejiang (Shen et al., 2009) . Its resistance to carbapenem was mainly due to producing KPC-2 carbapenem-hydrolysing b-lactamase, and DHA-1-type AmpC enzyme might contribute to higher levels of carbapenem resistance in accordance with previous studies (Smith Moland et al., 2003; Hossain et al., 2004) . Furthermore, KPC-2 and DHA-1 were located on a transferable plasmid, which has the same plasmid profile as seen in Klebsiella pneumoniae producing KPC-2 that is prevalent in our hospital (Kuai et al., 2010) . This indicated that it has a high potential to spread among clinical isolates and that detection of carbapenem-hydrolysing b-lactamases is urgently needed because carbapenems are one of the few remaining 5.4 Fig. 1 . Isoelectric focusing of b-lactamase preparations from Enterobacter aerogenes WX04 and its Escherichia coli transconjugant. The gel was stained with nitrocefin. Lanes: 1, Escherichia coli transconjugant of Enterobacter aerogenes WX04 KPC-2 (pI 6.7) and DHA-1 (pI 7.8); 2, Enterobacter aerogenes WX04 producing TEM-1 (pI 5.4), KPC-2 (pI 6.7) and DHA-1 (pI 7.8); 3 and 4, pIs of the b-lactamases were calculated by using the known pIs of TEM-1(pI 5.4), KPC-2 (pI 6.7), SHV-18 (pI 7.6) and ACT-1 (pI 9.0). Plasmid-mediated b-lactamases in Enterobacter aerogenes therapies for infections caused by high-level AmpC-or ESBL-producing Enterobacter species. In order to avoid an epidemic of strains producing KPCs, strict resistance surveillance and drug administration should be emphasized in this area.
